viimane versioon :
29/10/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Paclitaxel
keemiline struktuur
Kaubanduslikud nimed erinevates maades
Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist
Aclipak
Malaisia
Acoexcel
Mehhiko
Actaxel
Rootsi
Acupaxil
Maroko
Anzatax
Araabia Ühendemiraadid, Saudi Araabia, Türgi
Aritaxel
Saksamaa
Cantaxel
India
Clitaxel
Argentiina
Dalys
Argentiina
Difren
Argentiina
Ebetaxel
Austria, Saudi Araabia
Genexol
Ungari
Onxol
Ameerika ühendriigid
Paclinova
Argentiina
Paclired
Brasiilia
Paclitaxin
Holland
Parexel
Ecuador
Paxene
Hispaania, Kreeka, Soome, Taani
Poltaxel
Poola
Ribotax
Saksamaa
Taxol
Ameerika ühendriigid, Araabia Ühendemiraadid, Austraalia, Austria, Belgia, Egiptus, Hispaania, Horvaatia, Iirimaa, Itaalia, Jaapan, Kolumbia, Kreeka, Luksemburg, Malaisia, Maroko, Maroko, Poola, Portugal, Prantsusmaa, Rootsi, Saksamaa, Soome, Suurbritannia, Sveits, Taani, Türgi, Ungari, uus-Meremaa, Venetsueela
Taxomedac
Saksamaa
Vitax
Türgi
Viited : Paclitaxel
tüüp
avaldamine
38
ajaleht
Allwood MC, Martin HJ.
The extraction of diethylhexylphtalate (DEHP) from polyvinyl chloride components of intravenous infusion containers and administration sets by paclitaxel injection.
Int J Pharm 1996 ; 127: 65-71.
47
ajaleht
Burm JP, Jhee SS, Chin A, Moon YSK.
Stability of paclitaxel with ondansetron or ranitidine hydrochloride during simulated Y site administration.
Am J Hosp Pharm 1994 ; 51: 1201-1204.
57
ajaleht
Mayron D, Gennaro AR.
Stability and compatibility of granisetron hydrochloride in IV solutions and oral liquids and during simulated Y-site injection with selected drugs.
Am J Health-Syst Pharm 1996 ; 53: 294-304.
85
ajaleht
Trissel LA, Bready BB.
Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection.
Am J Hosp Pharm 1992 ; 49: 1716-1719.
140
ajaleht
Pearson SD, Trissel LA.
Leaching of diethylhexyl phthalate from polyvinyl chloride containers by selected drugs and formulation components.
Am J Hosp Pharm 1993 ; 50: 1405-1409.
151
ajaleht
Burm JP, Choi JS, Jhee SS, Chin A, Ulrich RW, Gill MA.
Stability of paclitaxel and fluconazole during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 2704-2706.
157
ajaleht
Xu QA, Trissel LA, Martinez JF.
Stability of paclitaxel in 5% dextrose injection or 0.9% sodium chloride injection at 4, 22, or 32°C.
Am J Hosp Pharm 1994 ; 51: 3058-3060.
158
ajaleht
Trissel LA, Xu QA, Kwan J, Martinez JF.
Compatibility of paclitaxel injection vehicle with intravenous administration and extension sets.
Am J Hosp Pharm 1994 ; 51: 2804-2810.
173
ajaleht
Williams DA, Naik A.
Precipitation of paclitaxel from continuous infusion fluids.
J Infus Chemother 1994 ; 4: 140-142.
182
ajaleht
Trissel LA, Gilbert DL, Martinez JF.
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 56-60.
248
ajaleht
Trissel LA, Martinez JF.
Turbidimetric assessment of the compatibility of taxol with 42 other drugs during simulated Y-site injection.
Am J Hosp Pharm 1993 ; 50: 300-304.
249
ajaleht
Trissel LA, Martinez JF.
Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1996 ; 53: 1041-1045.
250
ajaleht
Mazzo DJ, Nguyen-Huu JJ, Pagniez S, Denis P.
Compatibility of docetaxel and paclitaxel in intravenous solutions with polyvinyl chloride infusion materials.
Am J Health-Syst Pharm 1997 ; 54: 566-569.
251
ajaleht
Trissel LA, Gilbert DL, Martinez JF.
Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 2708-2713.
300
ajaleht
Trissel LA, Gilbert DL, Martinez JF.
Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1287-1292.
301
ajaleht
Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM.
Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1295-1300.
412
ajaleht
Waugh WN, Trissel LA, Stella VJ.
Stability, compatibility, and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers.
Am J Hosp Pharm 1991 ; 48: 1520-1524.
669
ajaleht
Chin A, Ramakrishnan RR, Yoshimura NN, Jeong EWS, Nii LJ, DiMeglio LS.
Paclitaxel stability and compatibility in polyolefin containers.
Ann Pharmacotherapy 1994 ; 28: 35-36.
872
ajaleht
Zhang YP, Xu QA, Trissel LA, Gilbert DL, Martinez F.
Compatibility and stability of paclitaxel combined with cisplatin and with carboplatin in infusion solutions.
Ann Pharmacotherapy 1997 ; 31: 1465-1470.
921
ajaleht
Trissel LA, Gilbert DL, Martinez JF.
Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration.
Hosp Pharm 1998 ; 33: 284-292.
1026
ajaleht
Mayron D, Gennaro AR.
Stability and compatibility of topotecan hydrochloride with selected drugs.
Am J Health-Syst Pharm 1999 ; 56: 875-881.
1286
ajaleht
Trissel LA, Xu QA, Gilbert DL.
Compatibility and stability of paclitaxel combined with doxorubicin hydrochloride in infusion solutions.
Ann Pharmacotherapy 1998 ; 32: 1013-1016.
1410
ajaleht
Trissel LA, Martinez JF, Simmons M.
Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 141-145.
1415
ajaleht
Trissel L.A, Gilbert D.L, Martinez J.F, Baker M.B, Walter W.V, Mirtallo J.M.
Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
JPEN 1999 ; 23: 67-74.
1423
ajaleht
Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518.
1496
ajaleht
Trissel LA, Martinez JF, Gilbert DL.
Screening cladribine for Y-site physical compatibility with selected drugs.
Hosp Pharm 1996 ; 31: 1425-1428.
1520
Labor
Etude de stabilité des médicaments en Ecoflac®
B Braun 2001
1522
Labor
Macoflex N®
Maco Pharma 2001
1625
ajaleht
Trissel LA, Saenz C, Williams YW, Ingram D.
Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2001 ; 5: 314-321.
1662
ajaleht
Trissel LA, Saenz CA, Ingram DS, Ogundele AB.
Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs.
J Oncol Pharm Practice 2002 ; 8: 33-37.
1741
ajaleht
Pfeifer RW, Hale KN, Cronquist SE, Daniels M.
Precipitation of paclitaxel during infusion by pump.
Am J Hosp Pharm 1993 ; 50: 2518-2521.
1865
ajaleht
Sautou-Miranda V, Brigas F, Vanheerswinghels S, Chopineau J.
Compatibility of paclitaxel in 5% glucose solution with ECOFLAC® low-density polyethylene containers - Stability under different storage conditions.
Int J Pharm 1999 ; 178: 77-82.
1925
ajaleht
Trissel LA , Williams KY, Gilbert DL.
Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
J Am Pharm Assoc 2000 ; 40: 515-519.
1940
ajaleht
Xu QA, Trissel LA.
Stability of palonosetron hydrochloride with paclitaxel and docetaxel during simulated Y-site administration.
Am J Health-Syst Pharm 2004 ; 61: 1596-1598.
1953
ajaleht
Trissel LA, Saenz CA, Ogundele AB, Ingram DS.
Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1956
Labor
Paclitaxel - Summary of Product Characteristics
Hospira UK Limited 2015
1961
ajaleht
Kim SC, Yoon HJ, Lee JW, Yu J, Park ES, Chi SC.
Investigation of the release behavior of DEHP from infusion sets by paclitaxel-loaded polymeric micelles.
Int J Pharm 2005 ; 293: 303-310.
1982
ajaleht
Trissel LA, Ogundele AB.
Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2005 ; 62: 834-837.
2014
ajaleht
Pourroy B, Botta C, Solas C, Lacarelle B, Braguer D.
Seventy-two-hour stability of Taxol® in 5% dextrose or 0.9% sodium chloride in Viaflo®, Freeflex®, Ecoflac® and Macoflex N® non PVC bags.
J Clin Pharm Ther 2005 ; 30: 455-458.
2172
ajaleht
Donyai P, Sewell GJ.
Physical and chemical stability of paclitaxel infusions in different container types.
J Oncol Pharm Practice 2006 ; 12, 4: 211-222.
2174
ajaleht
Kattige A.
Long-term physical and chemical stability of a generic paclitaxel infusion under simulated storage and clinical-use conditions.
EJHP Science 2006 ; 12, 6: 129-134.
2262
ajaleht
Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D.
Compatibility of doripenem with other drugs during simulated Y-site administratioN
Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2344
Labor
Stabilité physico-chimique de la gamme oncologie Ebewe Pharma France après dilution.
Ebewe Pharma 2009
3093
ajaleht
Tian J, Stella VJ.
Degradation of paclitaxel and related compounds in aqueous solutions III: Degradation under acidic pH conditions and overall kinetics
J Pharm Sci 2010 ; 99, 3 : 1288-1298.
3277
ajaleht
Yang Z, Cameron S, Paul H.
Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration.
Int J Pharm Compound 2012 ; 16, 1 : 82-85.
3578
Labor
Cisplatin - Summary of Product Characteristics
Accord Healthcare 2011
Mentions Légales